Outset Medical (OM) Restructuring Costs (2024)

Outset Medical's (OM) quarterly Restructuring Costs came in at $1.5 million in Q4 2024, up 7.14% on a QoQ basis from $1.4 million in Q3 2024.

Outset Medical (OM) Restructuring Costs (2024) Analysis & Trends

Outset Medical (OM) has 1 years of Restructuring Costs data on file, last reported at $1.5 million in Q4 2024.

On a quarterly basis, Restructuring Costs changed N/A year-over-year to $1.5 million in Q4 2024; TTM through Dec 2024 was $5.6 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1.5 million, down 40.0% from the prior year.
Restructuring Costs for Q4 2024 stood at $1.5 million, up from $1.4 million in the prior quarter.
Over the last five years, Restructuring Costs for OM reached as high as $2.7 million in Q1 2024 and fell as low as $1.4 million in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	183.94 Bn	176.64 Bn	6.27 Bn
2	Stryker	128.78 Bn	125.90 Bn	3.81 Bn
3	Medtronic	109.01 Bn	99.79 Bn	6.41 Bn
4	Boston Scientific	68.59 Bn	67.13 Bn	3.61 Bn
5	Edwards Lifesciences	47.66 Bn	43.99 Bn	1.29 Bn
6	GE HealthCare Technologies	28.36 Bn	26.07 Bn	1.98 Bn
7	Dexcom	28.30 Bn	27.18 Bn	750.30 Mn
8	Smith & Nephew	26.93 Bn	26.36 Bn	-
9	Koninklijke Philips	25.45 Bn	22.33 Bn	2.07 Bn
10	Outset Medical	78,728.30	-286.57 Mn	12.10 Mn

Download Data